In just 10 months, a start up biotech company named Axovant Sciences is giving jitters to world's leading biotech giants with its phenomenal rise. Axovant Sciences was founded with an investment of 33 crores by a 29 year old NRI named Vivek Ramaswamy in Boston in December last year.
Axovant sensors primarily develops medicine for Alzheimer's disease. Even the leading Biotech company Glaxo SmithKline failed to find the right medicine even after several years of research and stopped its research after inventing a drug that treats the early stage of Alzheimer's disease.
Vivek Ramaswamy bought the patent of the drug for 33 cross and continued the research which ended up getting progressive results and became a hot topic the Pharmaceutical industry. In June this year Axovant Sciences went public America's biggest Biotech I PO ever. All his company shares were bought for 19,980 crore rupees.
Hailing from Tamil Nadu, Vivek's family moved to America where his father used to work in GE and and his mother was a psychiatrist who used to treat Alzheimer's patients. Vivek graduated from the prestigious Harvard University and even worked at Hedge Funds as an analyst, before setting up Axovant Sciences.